Mitobronitol

This classification denotes a biomaterial with the molecular formula C6H12Br2O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 5UP30YED7N, chemically known as 1,2,3,4,5,6-hexanehexol but more generally known as mitobronitol, which bears US NIH Compound Identifier 453. European Medicines Agency schedules Mitobronitol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09001MIG. The term MITOBRONITOL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 23, No. 10 1969, List 9). World Health Organization schedules mitobronitol in its Anatomical Therapeutic Chemical (ATC) Classification. MITOBRONITOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule mitobronitol under HS 29055999 and SITC 51229. As of Q4 2014, MITOBRONITOL remains US FDA's Preferred Term for this commodity. Mitobronitol bears US NLM identifiers UMLS ID C0026236 and NCI Concept Code C659. SMILES: OC(C(O)C(O)CO)C(O)CO.